{"id":"https://openalex.org/W4361833199","doi":"https://doi.org/10.1158/0008-5472.22422302.v1","title":"Supplementary Figure S1 from Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity","display_name":"Supplementary Figure S1 from Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361833199","doi":"https://doi.org/10.1158/0008-5472.22422302.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22422302.v1","doi":"https://doi.org/10.1158/0008-5472.22422302.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22422302.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Local_Delivery_of_i_Ox40l_i_i_Cd80_i_and_i_Cd86_i_mRNA_Kindles_Global_Anticancer_Immunity/22422302/1/files/39868538.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Local_Delivery_of_i_Ox40l_i_i_Cd80_i_and_i_Cd86_i_mRNA_Kindles_Global_Anticancer_Immunity/22422302/1/files/39868538.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016794685","display_name":"Ole Audun Werner Haabeth","orcid":"https://orcid.org/0000-0002-1153-9250","observed_orcids":["https://orcid.org/0000-0002-1153-9250"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ole Audun Werner Haabeth","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1153-9250","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087121689","display_name":"Timothy R. Blake","orcid":"https://orcid.org/0000-0001-7548-1492","observed_orcids":["https://orcid.org/0000-0001-7548-1492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy R. Blake","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073511462","display_name":"Colin J. McKinlay","orcid":"https://orcid.org/0009-0005-7867-0244","observed_orcids":["https://orcid.org/0009-0005-7867-0244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin J. McKinlay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083214115","display_name":"Anders Aune Tveita","orcid":"https://orcid.org/0000-0002-0668-9262","observed_orcids":["https://orcid.org/0000-0002-0668-9262"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anders A. Tveita","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0668-9262","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067578649","display_name":"Adrienne Sallets","orcid":"https://orcid.org/0000-0002-3333-7609","observed_orcids":["https://orcid.org/0000-0002-3333-7609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adrienne Sallets","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009737401","display_name":"Robert M. Waymouth","orcid":"https://orcid.org/0000-0001-9862-9509","observed_orcids":["https://orcid.org/0000-0001-9862-9509"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert M. Waymouth","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9862-9509","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060002438","display_name":"Paul A. Wender","orcid":"https://orcid.org/0000-0001-6319-2829","observed_orcids":["https://orcid.org/0000-0001-6319-2829"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul A. Wender","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5083342021","display_name":"Ronald Levy","orcid":"https://orcid.org/0000-0003-2061-0650","observed_orcids":["https://orcid.org/0000-0003-2061-0650"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald Levy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7792999744415283,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7792999744415283,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.15970000624656677,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.04520000144839287,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ox40-ligand","display_name":"OX40L","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cd80","display_name":"CD80","score":1.0},{"id":"https://openalex.org/keywords/cd86","display_name":"CD86","score":1.0},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.7160000205039978},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6769999861717224},{"id":"https://openalex.org/keywords/costimulatory-molecules","display_name":"costimulatory molecules","score":0.6679999828338623},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2778297628","wikidata":"https://www.wikidata.org/wiki/Q5009843","display_name":"CD80","level":5,"score":0.8010273575782776},{"id":"https://openalex.org/C2781101188","wikidata":"https://www.wikidata.org/wiki/Q5009846","display_name":"CD86","level":4,"score":0.6784318089485168},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.647104024887085},{"id":"https://openalex.org/C2777275308","wikidata":"https://www.wikidata.org/wiki/Q234668","display_name":"Cart","level":2,"score":0.5398110747337341},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48954638838768005},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.42791491746902466},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20522305369377136},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12511861324310303},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10651609301567078},{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.07311472296714783},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06786727905273438},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.04160726070404053},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.0},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.22422302.v1","doi":"https://doi.org/10.1158/0008-5472.22422302.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22422302.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Local_Delivery_of_i_Ox40l_i_i_Cd80_i_and_i_Cd86_i_mRNA_Kindles_Global_Anticancer_Immunity/22422302/1/files/39868538.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22422302","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Local_Delivery_of_i_Ox40l_i_i_Cd80_i_and_i_Cd86_i_mRNA_Kindles_Global_Anticancer_Immunity/22422302","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22422302.v1","doi":"https://doi.org/10.1158/0008-5472.22422302.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22422302.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_Local_Delivery_of_i_Ox40l_i_i_Cd80_i_and_i_Cd86_i_mRNA_Kindles_Global_Anticancer_Immunity/22422302/1/files/39868538.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361833199.pdf","grobid_xml":"https://content.openalex.org/works/W4361833199.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361843869","https://openalex.org/W2911764398","https://openalex.org/W2740623805","https://openalex.org/W7056438957","https://openalex.org/W7203451997","https://openalex.org/W3198902724","https://openalex.org/W3201461107","https://openalex.org/W4412373951","https://openalex.org/W2892392161","https://openalex.org/W2010050763"],"abstract_inverted_index":{"OX40L,":[0],"CD80":[1],"and":[2,12],"CD86":[3,11],"mRNA-CART":[4],"treatment":[5],"increased":[6],"the":[7],"expression":[8],"of":[9],"CD80,":[10],"OX40L":[13],"protein":[14],"on":[15],"tumor":[16],"infiltrating":[17],"cells":[18]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-04-05T00:00:00"}